The U.S. Food and Drug Administration has granted Abbott 510(k) clearance for its Cataract Operating System 3 and Liquid Optics Interface 12.Both products are intended for use with the Catalys Precision Laser System, according to a company press release.
An important scientific breakthrough by a team of IRCM researchers led by Michel Cayouette, PhD, is being published today by The Journal of Neuroscience.
CHICAGO — Applied Genetic Technologies Corp. was awarded with the Innovator Award here at the Ophthalmology Innovation Summit, ahead of the American Academy of Ophthalmology annual meeting. The clinical-stage biotechnology company has developed adeno-associated virus-based gene therapies for X-linked retinoschisis, achromatopsia and X-linked retinitis pigmentosa.
CHICAGO — The National Space And Biomedical Research Institute of Baylor College of Medicine announced the launch of the Vision for Mars program, designed to better understand the mechanisms of and treatments for ocular health during space travel, at the Ophthalmology Innovation Summit here.Dorit B. Donoviel, PhD, deputy chief scientist and industry forum lead of the National Space Biomedical Research Institute, said the institution has observed papilledema occurring and correlating with longer time in space. They’re also finding globe flattening, increased optic nerve sheath diameter, hyperoptic-shift, choroidal folds, cotton wool (Read more...)
CHICAGO – As has become the tradition, the Ophthalmology Innovation Summit was held on the Thursday prior to the American Academy of Ophthalmology with a goal to be a common ground to discuss the opportunities and obstacles to ophthalmic innovation. Ocular Surgery News has captured the substance and spirit of the remarks made by the speakers here during the BioPharma Company Showcase. Henry Hsu, MD, founder and CEO of Allysta Pharmaceuticals discussed the company’s development of Aly1337, a small molecule multikinase inhibitor for the treatment of glaucoma.
A study looks at the outcomes of patients with vitreomacular adhesion who are managed with observation. Medscape Ophthalmology